Rx (Prescription Medicine)
USD $ 100.00
Gemtaz Infusmart 1.2gm 注射液是一种重要的药物，用于治疗多种癌症。其活性成分为吉西他滨，属于核苷类似物，通过干扰DNA合成和修复发挥作用，最终导致癌细胞死亡。吉西他滨常用于治疗胰腺癌、非小细胞肺癌、乳腺癌和卵巢癌，通常作为联合化疗方案的一部分。
Gemtaz Infusmart 1.2gm 注射液的剂量和用法由合格的医疗专业人员根据具体的癌症类型、分期、患者的整体健康状况以及对治疗的反应来确定。通常采用静脉给药。常见的不良反应可能包括疲劳、恶心、呕吐、发热、血细胞计数下降（导致感染和出血风险增加）、以及脱发。少见但严重的不良反应也可能发生，患者应立即向医生报告任何不寻常的症状。
Gemtaz Infusmart 1.2gm 注射液应储存在室温，避光并放在儿童不易触及的地方。严格遵循处方治疗方案并参加所有预定的监测和评估预约至关重要。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Gemcitabine. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
